Condition

Cervical Adenocarcinoma clinical trials and research

• 6Clinical trials
• 4Countries

Newest Cervical Adenocarcinoma clinical trials

All recruiting trials (6)

• Blood biomarkers to help detect and monitor cervical cancer

  This study tests whether a blood test using cfDNA and extracellular vesicles can help detect and track cervical cancer in adult women.

  Recruiting Queensland Centre for Gynaecological Cancer · Brisbane, Queensland · NCT07796672

• AVA6103 for advanced or metastatic FAP-positive solid tumors

  This study will test whether the experimental IV drug AVA6103 is safe and can help adults with advanced or metastatic FAP-positive cancers such as pancreatic, gastric/GEJ, cervical, or vulvar adenocarcinomas.

  Recruiting at 7 sites Phase 1 Avacta Life Sciences Ltd · Scottsdale, Arizona and 6 other locations · NCT07454642

• Short-course (hypofractionated) versus standard radiotherapy with cisplatin and brachytherapy for locally advanced cervical cancer in Uganda

  This trial tests whether a shorter, higher-dose radiotherapy schedule plus cisplatin and brachytherapy works as well and causes no more serious side effects than the usual longer schedule for women in Uganda with stage IB3–IIIC cervical cancer.

  Recruiting Phase 2 Uganda Cancer Institute · Kampala, Kampala · NCT07276360

• Nectin-4 targeted alpha radiotherapy [225Ac]Ac-AKY-1189 for advanced solid tumors

  This trial will try a Nectin‑4–targeted radioactive drug called [225Ac]Ac‑AKY‑1189 in adults with locally advanced or metastatic solid tumors, including certain bladder, breast, lung, and cervical cancers.

  Recruiting at 14 sites Phase 1 Aktis Oncology, Inc. · Duarte, California and 13 other locations · NCT07020117

• IN10018 plus nab-paclitaxel and cadonilimab for metastatic or recurrent gastric-type cervical adenocarcinoma.

  This trial will test whether combining IN10018 with nab-paclitaxel and cadonilimab helps adult women whose gastric-type cervical adenocarcinoma has come back or spread after prior chemotherapy.

  Recruiting at 2 sites Phase 2 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei and 1 other locations · NCT06654011

• External and internal radiation plus chemotherapy and immunotherapy for Stage IVB cervical cancer

  This trial will try adding external beam radiation and brachytherapy to chemotherapy (cisplatin and paclitaxel) plus immunotherapy (pembrolizumab and bevacizumab) to see if it is safe and helps people with newly diagnosed Stage IVB cervical cancer.

  Recruiting Phase 1/2 Jonsson Comprehensive Cancer Center · Los Angeles, California and 3 other locations · NCT06543576

Related topics

Quick answers

How many Cervical Adenocarcinoma clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in United States (3 trials), Uganda (1 trial), China (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 1: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →